Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Rifapentine labels and packages

Introduction

Rifapentine
FDA Package Insert (PRIFTIN®)
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages
Labels and Packages

Labels and Packages

PRINCIPAL DISPLAY PANEL – 150 mg blister NDC 0088-2100-03 Priftin® 150mg rifapentine sanofi-aventis U.S. LLC Peel at unsealed corners DO NOT CUT BLISTER

PRINCIPAL DISPLAY PANEL – 150 mg pouch NDC 0088-2100-03 Priftin® rifapentine 150mg 8 Tablets sanofi-aventis


PRINCIPAL DISPLAY PANEL – 150 mg carton NDC 0088-2100-03 Priftin® rifapentine 150mg 32 Tablets Four 8-Tablet Pouches sanofi-aventis [1]

References

References

  1. ↑ “PRIFTIN (RIFAPENTINE) TABLET, FILM COATED [SANOFI-AVENTIS U.S. LLC]”.

Adapted from the FDA Package Insert.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]